Empirical Asset Management LLC acquired a new position in Danaher Co. (NYSE:DHR - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 63,530 shares of the conglomerate's stock, valued at approximately $14,583,000.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Fort Pitt Capital Group LLC boosted its position in Danaher by 3.2% during the third quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate's stock worth $66,194,000 after purchasing an additional 7,421 shares in the last quarter. Good Life Advisors LLC acquired a new stake in Danaher in the 3rd quarter valued at $217,000. ORG Partners LLC increased its holdings in Danaher by 1,212.8% in the 4th quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate's stock worth $636,000 after acquiring an additional 2,559 shares in the last quarter. Harvest Portfolios Group Inc. lifted its holdings in Danaher by 1.2% during the third quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate's stock valued at $56,233,000 after purchasing an additional 2,465 shares in the last quarter. Finally, Stifel Financial Corp grew its position in shares of Danaher by 1.3% in the third quarter. Stifel Financial Corp now owns 847,348 shares of the conglomerate's stock valued at $235,583,000 after purchasing an additional 11,216 shares during the period. Institutional investors and hedge funds own 79.05% of the company's stock.
Danaher Trading Down 1.4 %
DHR traded down $3.49 on Friday, hitting $238.41. The company had a trading volume of 3,044,734 shares, compared to its average volume of 3,178,132. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The firm has a market cap of $172.20 billion, a P/E ratio of 45.50, a PEG ratio of 4.23 and a beta of 0.83. The company's fifty day moving average price is $234.99 and its 200 day moving average price is $253.37. Danaher Co. has a 1 year low of $222.53 and a 1 year high of $281.70.
Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.57 by $0.14. The business had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business's revenue was up 3.1% on a year-over-year basis. During the same period in the previous year, the firm earned $2.02 EPS. As a group, equities analysts expect that Danaher Co. will post 7.49 earnings per share for the current year.
Danaher Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be paid a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.45%. The ex-dividend date is Friday, December 27th. Danaher's dividend payout ratio (DPR) is 20.61%.
Wall Street Analyst Weigh In
A number of research analysts recently weighed in on the stock. Stephens reaffirmed an "overweight" rating and issued a $315.00 price target on shares of Danaher in a research note on Wednesday, October 23rd. Stifel Nicolaus lifted their price target on Danaher from $250.00 to $265.00 and gave the stock a "hold" rating in a research note on Wednesday, October 23rd. KeyCorp lifted their target price on shares of Danaher from $290.00 to $310.00 and gave the stock an "overweight" rating in a research note on Wednesday, October 23rd. Citigroup decreased their price target on shares of Danaher from $305.00 to $285.00 and set a "buy" rating on the stock in a research note on Monday, January 6th. Finally, StockNews.com cut shares of Danaher from a "buy" rating to a "hold" rating in a research note on Saturday, December 14th. Six equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $286.80.
Read Our Latest Report on Danaher
Danaher Profile
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Further Reading
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
